OVERVIEW

Fourth Annual Medical, Interventional & Surgical Inflammatory Bowel Disease (IBD) Symposium is organized by Columbia University Irving Medical Center (CUIMC), Department of Surgery and will be held on Aug 01, 2025 at Vivian and Seymour Milstein Family Heart Center, New York City, New York, United States of America.

Description:
The Fourth Annual Medical, Interventional, Surgical IBD Symposium will bring together leading experts in gastroenterology, surgery, and interventional medicine to explore the latest advancements in the management and treatment of inflammatory bowel disease (IBD). This one-day, CME-accredited event will focus on medical therapies, diagnostic challenges, IBD mimics, complications, and surgical interventions. The program will feature lectures from renowned specialists, followed by a case discussion session to provide practical insights into complex clinical scenarios. The symposium is structured to provide in-depth knowledge and updates on the current state of IBD therapies, including biologics, small molecular agents, and endoscopic treatments. Experts will also present strategies for managing IBD complications, such as cancer risks and postoperative monitoring. The interactive case discussions will offer participants an opportunity to engage with the panel of experts to review real-world clinical cases.

Learning Objectives:

Understand and apply the latest advancements in medical therapies for IBD, including anti-IL23 therapy, anti-TNF therapy, and small-molecule agents, to optimize patient outcomes.
Evaluate and manage the diagnostic challenges of IBD, including differentiating IBD from IBD mimics and identifying complications such as adenocarcinoma and squamous cell carcinoma in IBD patients.
Assess and develop individualized surgical treatment plans for IBD patients, including postoperative monitoring, endoscopic therapy, and the appropriate use of surgical interventions in Crohn’s disease and ulcerative colitis.